Viewing Study NCT03362060


Ignite Creation Date: 2025-12-25 @ 2:04 AM
Ignite Modification Date: 2026-01-06 @ 9:54 PM
Study NCT ID: NCT03362060
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-01
First Post: 2017-11-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PVX-410 Vaccine Plus Pembrolizumab in HLA-A2+ Metastatic Triple Negative Breast Cancer
Sponsor: Massachusetts General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module